Migraine Cocktail Treatment Regimen
The standard migraine cocktail treatment consists of sumatriptan 50-100 mg, metoclopramide 10 mg, and dexamethasone 4 mg, with the triptan serving as the primary abortive agent, the antiemetic addressing nausea and improving gastric motility, and the corticosteroid reducing recurrence rates. 1
Components and Dosing
1. Triptan (Sumatriptan)
- Dosage: 50-100 mg orally
- Route considerations:
- Contraindications: Ischemic vascular conditions, vasospastic coronary disease, uncontrolled hypertension, significant cardiovascular disease 1
2. Antiemetic (Metoclopramide)
- Dosage: 10 mg IV or orally 1
- Timing: Administer 20-30 minutes before or with the triptan 1
- Benefits:
- Treats nausea (a highly disabling symptom)
- Improves gastric motility, which may enhance oral medication absorption 1
- Contraindications: Pheochromocytoma, seizure disorder, GI bleeding, GI obstruction 1
- Side effects: Restlessness, drowsiness, diarrhea, muscle weakness, dystonic reaction 1
3. Corticosteroid (Dexamethasone)
- Dosage: 4 mg orally 5
- Purpose: Reduces headache recurrence when combined with a triptan and NSAID 5
- Evidence: Significantly reduces recurrence rates from approximately 60% to 23.4% when added to triptan+NSAID combinations 5
Administration Algorithm
Assess severity and symptoms:
Administer medications:
- Start with metoclopramide 10 mg (to address nausea and improve absorption)
- Follow with sumatriptan 50 mg (increase to 100 mg if previous response to 50 mg was inadequate)
- Add dexamethasone 4 mg to reduce recurrence risk
Monitoring and follow-up:
Important Clinical Considerations
Hepatic impairment: Maximum single sumatriptan dose should not exceed 50 mg in patients with mild to moderate hepatic impairment 2
Timing matters: Treating early during the mild pain phase gives significantly better outcomes than treating established attacks with moderate or severe pain 6
Common pitfalls:
Efficacy expectations: With sumatriptan 50 mg, approximately 58% of patients achieve headache relief after a single dose, increasing to 72% after a second dose 7